Inhibrx Biosciences (INBX) Operating Margin (2023 - 2025)
Inhibrx Biosciences (INBX) reported Operating Margin of 2106.85% for Q2 2025, up 15879115.0% year-over-year from N/an in Q2 2024, and up 95.78% quarter-over-quarter from 49928.0% in Q4 2024.
Inhibrx Biosciences (INBX) Operating Margin (2023 - 2025) Analysis & Trends
Inhibrx Biosciences (INBX) has 3 years of Operating Margin data on file, last reported at 2106.85% in Q2 2025.
- Operating Margin for Q2 2025 came in at 2106.85%, up 15879115.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 9644.64% (up 842777.0% YoY), and the FY2025 annual result was 10386.54%, up 15533746.0% from the prior year.
- Operating Margin climbed to 2106.85% in Q2 2025 per INBX's latest filing, from 49928.0% in the prior quarter.
- Over five years, Operating Margin peaked at 2106.85% in Q2 2025 and troughed at 160898.0% in Q2 2024.
- A 3-year average of 65773.81% and a median of 44219.04% in 2023 frame the typical range for Operating Margin.
- The sharpest annual moves came in 2024 and 2025: Operating Margin plunged 4452476 bps in 2024, then soared 15879115 bps in 2025.
- A 3-year view of Operating Margin shows it stood at 5403.24% in 2023, then slumped by 824 bps to 49928.0% in 2024, then soared by 96 bps to 2106.85% in 2025.
- Business Quant data shows INBX's Operating Margin at 2106.85% in Q2 2025, 49928.0% in Q4 2024, and 160898.0% in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -6.43% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 38.10% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Inhibrx Biosciences | 186.16 Mn | 186.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -2,106.85% |
| Dec 31, 2024 | -49,928.00% |
| Jun 30, 2024 | -160,898.00% |
| Dec 31, 2023 | -5,403.24% |
| Sep 30, 2023 | -38,510.08% |
| Jun 30, 2023 | -137,796.67% |